Methods of Imaging and Tracking Nucleic Acids in Cells

Short hairpin RNA compositions, methods of making and applications thereof

Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors

Compound usable as cationic lipid

Methods for diagnosis and treatment of type 1 diabetes

COMPOSITIONS FOR CONFERRING TOLERANCE TO VIRAL DISEASE IN SOCIAL INSECTS, AND THE USE THEREOF

Nucleic acid, pharmaceutical composition and conjugate containing nucleic acid, and use thereof

COMPOSITIONS AND METHODS FOR REDUCING SPLICEOPATHY AND TREATING RNA DOMINANCE DISORDERS

MULTIPLEXED SHRNAS AND USES THEREOF

OLIGONUCLEOTIDE-BASED PROTEOLYSIS TARGETING CHIMERA

RNA MOLECULES COMPRISING NON-CANONICAL BASE PAIRS

MODIFICATION OF SMALL RNAS FOR THERAPEUTIC USES

Serpina1 iRNA compositions and methods of use thereof

METHOD OF TREATING WASTING DISORDERS

Lipid formulations for nucleic acid delivery

Compositions and methods for mitigating pest infestation with

GENE THERAPIES FOR NEURODEGENERATIVE DISEASES

Inhibition of oxidative stress in atrial fibrillation

RNA INTERFERENCE IN DERMAL AND FIBROTIC INDICATIONS

Compositions and methods of inhibiting gene expression in a lung

SMAC/Diablo inhibitors useful for treating cancer

Complement component C3 iRNA compositions and methods of use thereof

ANTIBODY-OLIGONUCLEOTIDE CONJUGATES

CONJUGATED LIPOMERS AND USES THEREOF

METHODS OF TREATING SCHIZOPHRENIA AND OTHER NEUROPSYCHIATRIC DISORDERS

TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND DISORDERS ASSOCIATED WITH THE SPINAL CORD

DOWN-REGULATING GENE EXPRESSION IN INSECT PLANTS

TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

METHOD FOR TREATING CARDIOVASCULAR DISEASE

Nanometric pharmaceutical composition in the form of liposomes or nanoemulsion containing specific sequences of interference RNA

COMBINATION THERAPIES COMPRISING C/EBP ALPHA SARNA

Nucleic acid molecules and uses thereof

iRNA AGENTS WITH BIOCLEAVABLE TETHERS

Structurally designed shRNAs

SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Short/small hairpin RNA molecules

IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS

Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)

Compositions and methods for treating RSV-infections

INHIBITION OF CATALYTIC SITE COMMON TO MULTIPLE 3 ALPHA-OXIDOREDUCTASES FOR TREATMENT OF PROSTATE CANCER

COMBINATION THERAPIES FOR INNER EAR SENSORY HAIR CELL REGENERATION/REPLACEMENT

METHODS OF TREATING DISORDERS

RAAV-based compositions and methods for treating amyotrophic lateral sclerosis

Factor XII (Hageman Factor) (F12), KALLIKREIN B, PLASMA (FLETCHER FACTOR) 1 (KLKB1), and Kininogen 1 (KNG1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Polynucleotide and method for controlling insect infestation

Polynucleotide and method used for controlling insect invasion

Recombinant polypeptide production method

Methods for expressing proteins in axons

NEUTRAL LIPOSOMES CONTAINING BIOLOGICALLY ACTIVE AGENTS

GUAYULE WITH INCREASED RUBBER PRODUCTION AND YIELD

Oligonucleotides for modulating SCN9A expression

SHORT INTERFERING RNA TARGETING VARIANT C1858T OF GENE PTPN22

Use of PI3KC2B inhibitors for the preservation of vascular endothelial cell barrier integrity

RNAi Agents And Compositions for Inhibiting Expression of Angiopoietin-Like 3 (ANGPTL3), And Methods Of Use

Treatment of ophthalmic conditions with son of Sevenless 2 (SOS2) inhibitors

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING CD300C EXPRESSION INHIBITOR OR ACTIVITY INHIBITOR

Modified RNA agents with reduced off-target effect

Compositions and methods for improving strand biased

Engineering Extracellular Vesicles for Affinity Purification

Cationic amphiphilic polymers for codelivery of hydrophobic agents and nucleic acids

EDIBLE PLANT EXOSOME-LIKE NANOVECTORS FOR VACCINATION

METHODS OF SUPPORTING WEIGHT MAINTENANCE BY DECREASING THE ACTIVITY OF FAM46A

Inhibition of diacylglycerol kinase to augment adoptive T cell transfer

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

Composition for inhibiting CTGF expression

BIODEGRADABLE AND CLINICALLY-COMPATIBLE NANOPARTICLES AS DRUG DELIVERY CARRIERS

COMPOSITIONS AND METHODS FOR CONTROLLING LEPTINOTARSA

Methods of reducing virus molecule levels

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ANESTHESIA-INDUCED NEUROTOXICITY

Methods of treating porphyria

METHODS FOR REACTIVATING GENES ON THE INACTIVE X CHROMOSOME

AMYGDALAR NEURAL ENSEMBLE THAT ENCODES THE UNPLEASANTNESS OF PAIN

PEPTIDE/PARTICLE DELIVERY SYSTEMS

NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY

DIRECTED EVOLUTION

Polynucleotide and method for controlling insect invasion

COMPOSITIONS FOR MODULATING EXPRESSION OF C9ORF72 ANTISENSE TRANSCRIPT

Nucleic acid loaded extracellular vesicles

Targeting PAX2 for the treatment of breast cancer

Compositions and methods for treating pancreatitis

CANNABIS PLANTS HAVING MODIFIED EXPRESSION OF THCA SYNTHASE

Compositions and methods for treatment of dominant retinitis pigmentosa

Chirally-enriched double-stranded RNA agents

Methods and compositions for inhibiting detoxification response

Non-liposomal systems for nucleic acid delivery

RNA-INTERFERENCE-INDUCING NUCLEIC ACID MOLECULE ABLE TO PENETRATE INTO CELLS, AND USE THEREFOR

INHIBITION OF FOLLISTATIN

METHODS OF ACTIVATING CELLS VIA PTP 1B INHIBITION

Senile dementia treatment formulation and application thereof

Method for treating subject suffering from flavivirus infection

METHODS FOR DETERMINING THE PRESENCE OR RISK OF DEVELOPING FACIOSCAPULOHUMERAL DYSTROPHY (FSHD)

TEMPERATURE CONTROLLED DNA POLYMERASE INHIBITORS

ANTIFIBROTIC AGENT AND BIOMARKER FOR FIBROSIS

Compositions and methods for treating eye disorders

Agents for improved delivery of nucleic acids to eukaryotic cells

COMPOSITIONS AND METHODS OF USE OF ARC CAPSIDS

Method of allele specific silencing for the treatment of autosomal dominant Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof

AMPHIREGULIN GENE-SPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDE AND COMPOSITION FOR PREVENTING AND TREATING FIBROSIS-RELATED DISEASES AND RESPIRATORY DISEASES, COMPRISING SAME

SELF-MANAGEABLE ABNORMAL SCAR TREATMENT WITH SPHERICAL NUCLEIC ACID (SNA) TECHNOLOGY

Plant viral RNA delivery nanoparticles and uses thereof

Targeting ligands for therapeutic compounds

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF FACTOR V

Programmed cell death 1 ligand 1 (PD-L1) iRNA compositions and methods of use thereof

COMPOSITIONS AND METHODS FOR MODULATING MONOCYTE AND MACROPHAGE INFLAMMATORY PHENOTYPES AND IMMUNOTHERAPY USES THEREOF

Anti-PVRIG antibodies and methods of use

Treatment of fibrosis

SINGLE-STRANDED NUCLEIC ACID MOLECULE, AND PRODUCTION METHOD THEREFOR

Compositions and methods of treating muscle atrophy and myotonic dystrophy

Modified factor VII polypeptides for subcutaneous administration and on-demand treatment

Compositions And Methods For Enhancing Immunotherapy

CYTOBIOLOGICS AND THERAPEUTIC USES THEREOF

C/EBP ALPHA SARNA COMPOSITIONS AND METHODS OF USE

Methods of treating cancers

Methods for production of MSC-derived exosomes

Control of plant pests using RNA molecules

Therapeutic inhibition of lactate dehydrogenase and agents therefor

Compositions and methods for inhibiting gene expression of Hif2alpha

Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA

MODULATORS OF ENaC EXPRESSION

Method for treating cancer by disabling-BRCA1/FANCM interaction

Nucleic acid-polypeptide compositions and uses thereof

Skin-permeating carrier containing nucleic acid complex and use thereof

REAGENTS FOR TREATMENT OF HEPATITIS B VIRUS (HBV) INFECTION AND USE THEREOF

COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

POROUS SILICON MATERIALS COMPRISING A METAL SILICATE FOR DELIVERY OF THERAPEUTIC AGENTS

Increasing plant oil content by altering a negative regulator of acetyl-CoA carboxylase

Compositions and methods for use in controlling mosquito-borne viruses

METHODS AND AGENTS FOR ENHANCING T CELL THERAPIES

Glucokinase (GCK) iRNA compositions and methods of use thereof

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

COMPOSITIONS AND METHODS FOR TARGETING GLYPICAN-2 IN THE TREATMENT OF CANCER

Compositions and methods for improving persistence of cells for adoptive transfer

Use of SRSF3 agents for the treatment and/or prevention of neurological conditions, cancer, bacterial infections or viral infections

COMPOSITIONS AND METHODS FOR INHIBITING THE PRODUCTION OR ACTIVITY OF D-2HYDROXYGLUTARATE IN SUBJECTS AFFLICTED WITH CANCER

Compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions

Ophthalmic Delivery Device And Ophthalmic Active Agent Containing Compositions

Endomucin inhibitor as an anti-angiogenic agent

Allele-specific silencing therapy for dynamin 2-related diseases

TMPRSS6 iRNA compositions and methods of use thereof

METHODS AND COMPOSITIONS FOR TREATING A PROPROTEIN CONVERTASE SUBTILISIN KEXIN (PCSK9) GENE-ASSOCIATED DISORDER

TREATMENT OF ANGIOPOIETIN LIKE 7 (ANGPTL7) RELATED DISEASES

Modulation of alternative MDM2 splicing

Agents useful in treating facioscapulohumeral muscular dystrophy

AGENTS USEFUL IN TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

ARC PROTEIN EXTRACELLULAR VESICLE NUCLEIC ACID DELIVERY PLATFORM

Tumor immunotherapy target and application thereof

Targeting P18 for mTOR-related disorders

POLYPEPTIDES SELF-ASSEMBLING INTO NANOPARTICLES

Aptamer Compositions and Methods of Use Thereof

Composition and Methods of Controllable Co-Coupling Polypeptide Nanoparticle Delivery System for Nucleic Acid Therapeutics

RNA/DNA HYBRID NANOPARTICLES MODIFIED WITH SINGLE STRANDED RNA TOEHOLDS AND USES THEREOF

NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

Methods for Improving Leptin Sensitivity for the Treatment of Obesity and Diabetes

Methods of inhibiting formation of alpha synuclein aggregates

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF CD274/PD-L1 GENE

Modulation of gene expression and screening for deregulated protein expression

Compositions and methods to treat cancer

Methods and compositions for promoting survival and proliferation of endothelial cells and stimulating angiogenesis

MYC NUCLEIC ACIDS AND USES THEREOF

PHARMACEUTICAL COMPOSITION CONTAINING COMPLEX OF CHEMICALLY-MODIFIED siRNA AND SCHIZOPHYLLAN

HAEMATOPOIETIC STEM CELL TREATMENT

Compositions and methods for treating pulmonary vascular disease

Beta-catenin inhibitors in cancer immunotherapy

Use of trinucleotide repeat RNAs to treat cancer

Silencing of HNF4α-P2 isoforms with siRNA to improve hepatocyte function in liver failure

REDUCED SIZE SELF-DELIVERING RNAI COMPOUNDS

SiRNAs with vinylphosphonate at the 5′ end of the antisense strand

Targeted delivery system

VISTA-Ig constructs and the use of VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders

CD71 binding fibronectin type III domains

MODULATING IMMUNE RESPONSE VIA TARGETING OF OLFACTORY RECEPTOR ACTIVITY

Methods and compositions related to T-cell activity

PLANT GENOME EDITING

FIDGETIN-LIKE 2 AS A TARGET TO ENHANCE WOUND HEALING

Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

Methods and compositions for reducing immunosuppression by tumor cells

RNAI CONSTRUCTS FOR INHIBITING PNPLA3 EXPRESSION AND METHODS OF USE THEREOF

METHOD OF TREATING A MAMMAL WITH DIABETES ASSOCIATED KIDNEY DISEASE USING LOCAL ADMINISTRATION OF STEM CELLS WITH TRANSIENTLY REDUCED p53

COMPOUNDS AND METHODS FOR REDUCING SPDEF EXPRESSION

Methods and compositions for the specific inhibition of Complement Component 5(C5) by double-stranded RNA

RNAI TARGET GENE THAT IS HIGHLY LETHAL TO APHIDS AND USE THEREOF

Two-tailed self-delivering siRNA

Method to synthesize a biodegradable dextran for agent delivery

Modified Natural Killer Cells and Natural Killer Cell Lines Having Increased Cytotoxicity

COMPOSITIONS AND METHODS FOR INHIBITION OF NUCLEAR-PENETRATING ANTIBODIES

TREATMENT OF TINNITUS THROUGH MODULATION OF CHLORIDE CO-TRANSPORTER NKCC1 IN THE AUDITORY SYSTEM

COMPOSITIONS AND METHODS FOR MEMBRANE PROTEIN DELIVERY

Plant Vectors, Compositions and Uses Relating Thereto

METHODS OF GENE THERAPY

Chiral control

Increasing RNAi efficiency through single nucleotide mismatches

EGFL6 specific monoclonal antibodies and methods of their use

DYNAMIN 2 INHIBITOR FOR THE TREATMENT OF DUCHENNE'S MUSCULAR DYSTROPHY

Inhibitors of metastasis

Three-dimensional self-assembled nucleic acid nanoparticles and use thereof

Methods and compounds for improved immune cell therapy

Engineered immune cells resistant to tumor microenvironment

Methods for treatment or prevention of leukemia

Heterocyclic carboxylate compounds as glycolate oxidase inhibitors

METHODS AND COMPOSITIONS OF INSECT CONTROL

METHODS FOR IDENTIFYING THERAPEUTIC AGENTS WHICH INTERACT WITH STK24

ANTI-FIBROTIC COMPOSITIONS COMPRISING FENDRR OR FRAGMENTS OR VARIANTS THEREOF AND METHODS OF PRODUCTION AND USE THEREOF

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY DISEASE OR DISORDER

Conditional-siRNAS and uses thereof in treating acute myeloid leukemia

Mammalian cells for producing a secreted protein

Nucleic acids for inhibiting expression of LPA in a cell

Antibodies and fragments thereof that bind hepatitis B virus protein X

Methods of producing cells resistant to HIV infection

METHODS AND COMPOSITIONS FOR MODULATING CANCER STEM CELLS

Methods for treating triple-negative breast cancer

METHOD FOR PRODUCING SINGLE-STRAND RNA

Ras opposite (ROP) and related nucleic acid molecules that confer resistance to coleopteran and/or hemipteran pests

THERAPEUTIC MODULATION OF TUMOR SUPPRESSORS USING EXOSOMES

O-METHYL RICH FULLY STABILIZED OLIGONUCLEOTIDES

Targeting cancer-associated long non-coding RNAs

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING CD300E INHIBITOR AS ACTIVE INGREDIENT

RNA nanoparticles for brain tumor treatment

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

METHODS FOR TREATING INFLAMMATION

Methods and Compositions to Alleviate Vascular Permeability

Extraction of plant source “medicinal soup” and manual preparation of “herbal medicine” and related products

Methods of attenuating an immune response by inhibition of BFL1

MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes

Cationic polymers

Method of treating and prognosing scoliotic patient subgroups

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

Simultaneous gene silencing and suppressing gene silencing in ihe same cell

RNAi constructs for inhibiting ASGR1 expression and methods of use thereof

MUCOSAL HEALING PROMOTER

Products and Methods for Treatment of Familial Amyotrophic Lateral Sclerosis

OLIGONUCLEOTIDE DERIVATIVE OR SALT THEREOF

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

RNA Modulating Oligonucleotides with Improved Characteristics for the Treatment of Duchenne and Becker Muscular Dystrophy

Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof

SHRNA EXPRESSION CASSETTE, POLYNUCLEOTIDE SEQUENCE CARRYING SAME, AND APPLICATION THEREOF

Methods of delivering anionic agents in vivo using non-viral nanoparticle-based delivery systems

Compositions and methods for delivery of biomacromolecule agents

Methods and compositions for a HIV based delivery system

TREATMENT AND PREVENTION OF VIRAL INFECTION

COMPOSITIONS AND METHODS FOR NUCLEIC ACID TRANSFER

SIRT1-saRNA compositions and methods of use

Promotion of cardiomyocyte proliferation and regenerative treatment of the heart by inhibition of microRNA-128

Aminoalcohol lipidoids and uses thereof

APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS

RNAi agents for hepatitis B virus infection

MULTICISTRONIC EXPRESSION CONSTRUCTS

METHODS OF TREATING CANCERS WITH GPR132 INHIBITORS

Angiotensinogen (AGT) iRNA compositions and methods of use thereof

METHODS OF MODULATING NKX6.3

HETERODUPLEX NUCLEIC ACID MOLECULES AND USES THEREOF

Modulation of transthyretin expression

Methods and compositions for the specific inhibition of antithrombin 3 (AT3) by double-stranded RNA

Methods for Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Reduction

INTEGRIN TARGETING LIGANDS AND USES THEREOF

LOADING OF EXTRACELLULAR VESICLES THROUGH IMPARTING OF MECHANICAL SHEAR

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

Further novel oligonucleotide-ligand conjugates

Compounds and methods for reducing FXI expression

Methods and compositions for treating inflammatory diseases

Inhibitors Of Lactate Transporters For Use In The Treatment Of Inflammatory Diseases

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

Medicine for treating disorders of glucose and/or lipid metabolism and a method of treating glucose and/or lipid metabolic disorders

OLIGONUCLEOTIDES COMPRISING ACYCLIC AND ABASIC NUCLEOSIDES AND ANALOGS

COMPOSITIONS AND METHODS DIRECTED TO TREATING LIVER FIBROSIS

METHOD FOR OPENING TIGHT JUNCTIONS

Branched oligonucleotides

Microrna and uses thereof in prevention and/or treatment of fibroplasia medical sign and/or syndrome

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

INHIBITION OF ZSCAN4 FOR INHIBITION OF TUMOR GROWTH

Compositions and methods for modulating left-right differentiation factor (LEFTY) and bone morphogenic factor (BMP)

Nucleic acid linked to a trivalent glycoconjugate

Vesicles comprising a PTEN inhibitor and uses of same

Delivery across cell plasma membranes

Modified oligonucleotides targeting SNPs

Gene-regulating compositions and methods for improved immunotherapy

Hexameric tetrahedral RNA nanostructures

INTEGRIN TARGETING LIGANDS AND USES THEREOF

Methods and compositions for control of arthropod pests

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

Interfering RNA molecules

Compositions and methods for inhibiting GYS2 expression

Translocation and mutant ROS kinase in human non-small cell lung carcinoma

RNA interference in ocular indications

Hippo and dystrophin complex signaling in cardiomyocyte renewal

Extended dicer substrate agents and methods for the specific inhibition of gene expression

METHODS AND COMPOSITIONS FOR TREATING VITILIGO

Compositions and methods for treating and preventing inflammation

Enhanced immune cells using dual shRNA and composition including the same

Development of polylysine:epigallocatechin-3-o-gallate and dsRNA polyplexes for control of mosquitoes

Delivery across cell plasma membranes

Oligonucleotides for modulating TMEM106B expression

Methods and compositions for diagnosing and treating prostate cancer based on long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growth